Navigation Links
Wheelchair Tennis Tournament Draws Athletes Throughout California
Date:4/18/2008

- Charity Event to Benefit Sharp Rehabilitation Services -

SAN DIEGO, April 18 /PRNewswire/ -- The San Diego Business Clubs America will hold its second annual charity event, a Wheelchair Tennis Tournament and Luau, at Barnes Tennis Center in Point Loma on June 20th and 21st. More than 100 disabled/wheelchair-bound professional, semi-professional and recreational athletes from throughout California are expected to participate. This year, representatives from the Guinness Book of World Records have been invited to sanction the event as the largest wheelchair tennis tournament in the world.

Last year $70,000 was raised to benefit Sharp Rehabilitation Services. Proceeds from this year's event also will go to Sharp, a leader in improving the way people live following catastrophic injury or illness and assisting them in reaching their greatest potential. Sharp's primary focus is the support and rehabilitative care of people who have suffered spinal cord injuries, brain injuries or strokes. Proceeds from the Wheelchair Tennis Tournament will go toward sports recreation and wellness programs, as well as equipment to enhance mobility and exercise ability.

The San Diego Business Club America is a national membership-driven business development organization that serves the middle market business community and includes many prestigious local businesses. Sponsors of the charity event include Solar Turbines, Nielsen Construction, Cymer and Motorola.

To find out more about the event or if you are interested in participating, please visit http://www.wheelchairtennisandluau.com, or call 858-592-7632.


'/>"/>
SOURCE Business Clubs America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Worlds Lightest, Rigid, Folding Frame Wheelchair now in Production
2. Wheelchair Professionals Selects Authentidates Inscrybe Healthcare Platform to Streamline Mobility Order Processing
3. The SCOOTER Store Donates Power Wheelchair to New Braunfels Car Crash Victim
4. Scooter Store Executives to Deliver Power Wheelchair Donation to New Braunfels Car Crash Victim
5. Former Actor has Mobility Restored With Power Wheelchair Gift From The Scooter Store
6. Disabled Sacramento Woman, 110, Receives Power Wheelchair Donation from The SCOOTER Store
7. Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store
8. Philadelphia Police Officer Helps Amputee Receive Power Wheelchair From The SCOOTER Store
9. The SCOOTER Store Donates Power Wheelchair as a Birthday Gift to Iraqi War Hero
10. American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare
11. Knights Distribute $1 Million Worth of Wheelchairs to Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2014)... Irritable bowel syndrome (IBS) belongs to the most ... sixty per cent of the workload of gastrointestinal ... IBS is bloating, which reduces quality of life ... For quite a long time, IBS was believed ... to this view, recent findings suggest that IBS ...
(Date:3/7/2014)... treatment for individuals with autism has been the focus ... these studies led the American Academy of Child and ... treating autism. Researchers led by Yale Child Study Center ... parameters in the Feb. issue of the Journal ... . , "Early diagnosis of children with autism ...
(Date:3/7/2014)... March 7, 2014 In association with ... Oncology (ASCO) has named Dr. Daniel D. Von ... 50 doctors who over the past half-century have ... Hoff, M.D., FACP, is Physician-In-Chief and Distinguished Professor ... Chief Scientific Officer for Scottsdale Healthcare,s Virginia G. ...
(Date:3/7/2014)... may have only had one glass of wine with dinner, ... hit you hard enough to make you a dangerous driver., ... party like you used to. , Sara Jo Nixon, Ph.D., ... the University of Florida and doctoral candidate Alfredo Sklar tested ... skills of two age groups: 36 people ages 25 to ...
(Date:3/7/2014)... TORONTO, March 7, 2014 -- A new study ... years of declining, the rates of teenagers coming ... dropping between 2006 and 2010. , Suicide-related behaviours ... Using data from the Institute for Clinical Evaluative ... 2006, the rates of teenagers coming into Ontario ...
Breaking Medicine News(10 mins):Health News:IBS and bloating: When the gut microbiota gets out of balance 2Health News:IBS and bloating: When the gut microbiota gets out of balance 3Health News:New guidelines employ a team approach to autism diagnosis and care 2Health News:TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is honored by ASCO 2Health News:For older drivers, study finds, 1 drink may be 1 too many 2Health News:For older drivers, study finds, 1 drink may be 1 too many 3Health News:After years of improving, rates of youth suicide-related behaviors stopped declining 2
... can prevent the spread of melanoma// and other forms of ... a chemical found in turmeric, can block a biological pathway ... The chemical in the spices inhibits a protein called nuclear ... abnormal inflammations that can lead to a number of disorders ...
... vegetables and foods high in fibre can significantly// lower cholesterol ... ,Western cuisines are not so high in fibre and so ... ,10 healthy individuals were taken as the experimental group. ... diets were a vegetarian diet rich in fruits, vegetables and ...
... Expression of gene may be responsible for various immune ... the genes that cause two different form of immune ... Variable Immunodeficiency (CVID). ,Immune deficiency syndrome may be ... are generally caused by defects in the cells and ...
... or Vitamin B9 has been known to help in the ... now. Due to this reason it is administered to pregnant ... Netherlands has proposed that this vitamin can slow down the ... long study involved 818 subjects (both men and women) with ...
... on their genetic makeup, says a new study.// ... the same way even if they live a lifestyle totally ... Berkeley National Laboratory had looked into the health record of ... had a more sedentary life than another., ,The ...
... randomized trial published in Lancet Oncology, laparoscopic surgery// could ... the right, left, and sigmoid colon. The multicenter COLOR ... the short-term benefits of laparoscopic colectomy for cancer as ... been assigned to laparoscopic surgery and 621 patients to ...
Cached Medicine News:Health News:Fibre Rich Food A Boon For Lowering Cholesterol 2
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... A drug delivery system is one ...
(Date:1/15/2014)...  A novel wearable injector slightly larger than an ... for patients to self-inject prescription drugs in the large ... including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... expected to grow to $220B by 2018, according to ... type of injector that does not exist today for ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) ... the fourth quarter of 2013 on Monday, February 3, ... for release after the close of trading. ... hold a conference call to discuss the operating highlights ... months ended December 31, 2013 on February 3, 2014, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... - New data from an,investigational study released ... Scientific Sessions showed that initial,combination therapy with ... markers of beta cell,function in patients with ... determines the ability of the body to ...
... RICHMOND, Va.--(BUSINESS WIRE)--Jun 26, 2007 - Insmed ... and approval of drugs for the treatment ... noted the publication of,promising results of research ... insulin-like growth factor binding protein-3,(IGFBP-3) in the ...
Cached Medicine Technology:An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 2An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 3An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 7An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 8An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 9An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 10An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 11An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 12An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 13An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 14An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 15An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 16An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 17An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 18An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 19An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 20An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 21An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 22An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 23An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 24An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 25An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 26An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 27An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 28An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 29An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 30An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 31An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 32Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of,Blindness in Premature Infants 2Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of,Blindness in Premature Infants 3
US Autoflow Single Chamber Stackable Water-Jacketed CO2 Inc.w/ Humidity Display and Control...
... Dual Media Set, different from commonly used ... or other specially prepared medium, contains two ... (OB). For cell expansion, E. coli cells ... of the recombinant protein is almost completely ...
3.0% Tryptone, 2.0% Yeast Extract, 1.0% MOPS free acid, 2.0% Glucose....
0.3% Yeast Extract, 0.3% Malt Extract, 0.5% Peptone, and 1.0% Glucose....
Medicine Products: